Nothing Special   »   [go: up one dir, main page]

HK1111894A1 - Acid containing oxaliplatin formulations - Google Patents

Acid containing oxaliplatin formulations

Info

Publication number
HK1111894A1
HK1111894A1 HK08106611A HK08106611A HK1111894A1 HK 1111894 A1 HK1111894 A1 HK 1111894A1 HK 08106611 A HK08106611 A HK 08106611A HK 08106611 A HK08106611 A HK 08106611A HK 1111894 A1 HK1111894 A1 HK 1111894A1
Authority
HK
Hong Kong
Prior art keywords
acid containing
containing oxaliplatin
oxaliplatin formulations
formulations
acid
Prior art date
Application number
HK08106611A
Other languages
English (en)
Inventor
Darryl Vanstone Whittaker
Aikun Julie Liu
Original Assignee
Mayne Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904627A external-priority patent/AU2003904627A0/en
Application filed by Mayne Pharma Ltd filed Critical Mayne Pharma Ltd
Publication of HK1111894A1 publication Critical patent/HK1111894A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK08106611A 2003-08-28 2008-06-16 Acid containing oxaliplatin formulations HK1111894A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003904627A AU2003904627A0 (en) 2003-08-28 Pharmaceutical Formulation

Publications (1)

Publication Number Publication Date
HK1111894A1 true HK1111894A1 (en) 2008-08-22

Family

ID=34230045

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08106611A HK1111894A1 (en) 2003-08-28 2008-06-16 Acid containing oxaliplatin formulations

Country Status (11)

Country Link
US (5) US20050090544A1 (xx)
EP (2) EP1680103A4 (xx)
JP (4) JP2007504098A (xx)
CN (3) CN101022790A (xx)
CA (1) CA2537170A1 (xx)
DE (1) DE112004001563T5 (xx)
GB (1) GB2421911A (xx)
HK (1) HK1111894A1 (xx)
NO (1) NO20061417L (xx)
NZ (1) NZ545591A (xx)
WO (1) WO2005020980A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
JP2007504098A (ja) * 2003-08-28 2007-03-01 メイン・ファーマ・リミテッド 酸を含むオキサリプラチン製剤
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (en) * 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
WO2009087660A1 (en) * 2007-11-12 2009-07-16 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
JP5759464B2 (ja) 2009-09-21 2015-08-05 ジェイダブリュー ファーマシューティカル コーポレイション オキサリプラチンのナノ粒子及びその製造方法
JP5929607B2 (ja) * 2012-08-06 2016-06-08 ニプロ株式会社 オキサリプラチン製剤
SG11201508515WA (en) * 2013-04-26 2015-11-27 Sanofi Sa Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl piperazin-1 -yl)-3-oxo-propryl]amide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US19514A (en) * 1858-03-02 Improvement in seeding-machines
AU2989695A (en) 1994-08-08 2000-03-07 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation
EP0897389B1 (fr) * 1996-03-11 2002-07-03 Yoshinori Kidani Complexes de platine dinucleaires, procede pour leur preparation et compositions pharmaceutiques en contenant
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
BRPI0013613B8 (pt) 1999-08-30 2021-05-25 Debiopharm Sa composição farmacêuticamente estável de oxaliplatina para administração parenteral.
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
JP2007504098A (ja) * 2003-08-28 2007-03-01 メイン・ファーマ・リミテッド 酸を含むオキサリプラチン製剤
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions

Also Published As

Publication number Publication date
JP6078593B2 (ja) 2017-02-08
NO20061417L (no) 2006-03-28
CN101022790A (zh) 2007-08-22
CA2537170A1 (en) 2005-03-10
US20060264501A1 (en) 2006-11-23
EP1680103A1 (en) 2006-07-19
JP2007504098A (ja) 2007-03-01
NZ545591A (en) 2008-11-28
JP2014080426A (ja) 2014-05-08
CN102048723A (zh) 2011-05-11
US20100035982A1 (en) 2010-02-11
US20100063145A1 (en) 2010-03-11
WO2005020980A1 (en) 2005-03-10
EP1680103A4 (en) 2009-03-25
CN101703467A (zh) 2010-05-12
GB0606187D0 (en) 2006-05-10
DE112004001563T5 (de) 2006-07-27
US20050090544A1 (en) 2005-04-28
JP2015180699A (ja) 2015-10-15
EP2243480A1 (en) 2010-10-27
JP2012072191A (ja) 2012-04-12
GB2421911A (en) 2006-07-12
JP2008201804A (ja) 2008-09-04
US20070155833A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
HK1111894A1 (en) Acid containing oxaliplatin formulations
IL162642A0 (en) Formulations
IL158493A0 (en) Pharmaceutical compositions containing venlafaxine
GB0302671D0 (en) Pharmaceutical formulations
EP1681053A4 (en) COMPOSITION WITH REDUCED COENZYME Q
GB0319874D0 (en) Novel formulation
HK1084670A1 (en) Pharmaceutical compositions comprising cabbinochreme type compounds
IL171942A0 (en) Compositions containing ecteinascidin-743
EP1646355A4 (en) PHARMACEUTICAL FORMULATIONS
GB0323701D0 (en) Formulations
GB0318448D0 (en) Formulation
EP1673073A4 (en) SLOW RELEASE FORMULATIONS
EP1584320A4 (en) COSMETIC COMPOSITION WITH GLYCERYLAMINO-ACID DERIVATIVES
GB0302672D0 (en) Pharmaceutical formulations
DE60327253D1 (de) Nahrungszusammensetzung enthaltend l(+)-milchsäure
EP1675548A4 (en) RIFALAZIL FORMULATIONS
GB0312195D0 (en) Formulation
EP1655029A4 (en) MEDICINAL COMPOSITIONS
ZA200409494B (en) Cosmetic compositions containing salts of malonic acid.
IL155435A0 (en) Solid biocide formulations
GB0307765D0 (en) Tissue-adhesive formulations
IL158172A0 (en) Pharmaceutical compositions containing (-)-hydroxycitric acid
GB0320522D0 (en) Formulation
AU2003265432A8 (en) Polyionic organic acid formulations
GB2441445A8 (en) Acid containing oxaliplatin formulations

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240822